Saturday, July 11, 2026

pharma

TORAY INTERNATIONAL U.K

TORAY INTERNATIONAL U.K drug portfolio — 8 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

GB HQ
2 Employees
EMA registrant Type
Company details
Status
Public
HQ
GB
Employees
2
Programs
1
Drugs
8
Patents
0
Intelligence · Drug Pipeline

TORAY INTERNATIONAL U.K pipeline

Portfolio lens on 8 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

TORAY INTERNATIONAL U.K drug portfolio — 8 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

8 compounds
  1. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  2. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  3. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  4. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  5. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  6. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  7. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.

  8. Development asset linked to TORAY INTERNATIONAL U.K in public FDA and regional records.